Danilo Parolini
Overview
Explore the profile of Danilo Parolini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Nardi P, Mistrangelo M, Burtulo G, Passoni P, Slim N, Ronzoni M, et al.
J Surg Oncol
. 2020 Sep;
123(1):315-321.
PMID: 32964456
Background And Objectives: The aim of our study was to analyze the results of selective inguinal node irradiation in patients with anal cancer, based on the biopsy of the inguinal...
2.
Parmiani G, Pilla L, Corti A, Doglioni C, Cimminiello C, Bellone M, et al.
Oncoimmunology
. 2015 May;
3(11):e963406.
PMID: 25941591
Administration of NGR-TNF, a tumor vessel-targeting and tumor necrosis factor α TNFα) peptide conjugate, with immunotherapy has been shown to inhibit tumor growth in mice. Thus, we planned a Phase...
3.
Parmiani G, Russo V, Maccalli C, Parolini D, Rizzo N, Maio M
Hum Vaccin Immunother
. 2014 Dec;
10(11):3175-8.
PMID: 25483658
Interest for cancer vaccination started more than 30 years ago after the demonstration that both in animal models and later on in patients it is possible to generate anti-tumor immune...
4.
Mazzarella T, Cambiaghi V, Rizzo N, Pilla L, Parolini D, Orsenigo E, et al.
Cancer Immunol Immunother
. 2011 Dec;
61(8):1169-82.
PMID: 22207316
Tumor-infiltrating lymphocytes (TILs) have been successfully used for adoptive cell transfer (ACT) immunotherapy; however, due to their scarce availability, this therapy is possible for a limited fraction of cutaneous melanoma...